Search research articles
Contact Us
Filters
Showing results (461-470 of 488) with videos related to
Page
of 49
Sort By:
Science Advances
|
June 5, 2026
The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes
Nicola Marrano, Anna Borrelli, Giuseppina Biondi, et al.
Open Forum Infectious Diseases
|
August 6, 2025
Comparative Analysis of Initial Full Blood Count Parameters in Adults Infected With <i>Plasmodium falciparum</i> for Classification of Disease Severity and Previous Exposure Across Endemic (Gabon) and Nonendemic (Germany) Settings
Cäcilie von Wedel, Lars Christian Matthies, Clemens Dierks, et al.
Ebiomedicine
|
October 15, 2023
Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial
Dorothea Ekoka Mbassi, Ghyslain Mombo-Ngoma, Jana Held, et al.
BMC Cancer
|
March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
Ermelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon
Ghyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, et al.
Malaria Journal
|
January 3, 2023
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
Adama Gansane, Moussa Lingani, Adoke Yeka, et al.
Breast (Edinburgh, Scotland)
|
July 26, 2024
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, et al.
Plos Neglected Tropical Diseases
|
May 21, 2024
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting
Gerrit Burger, Rafiou Adamou, Ruth Kreuzmair, et al.
BMJ Open
|
July 1, 2016
Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study
Ghyslain Mombo-Ngoma, Jean Rodolphe Mackanga, Raquel González, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 488) with videos related to
Sort By:
Page
of 49
Science Advances
|
June 5, 2026
The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes
Nicola Marrano, Anna Borrelli, Giuseppina Biondi, et al.
Open Forum Infectious Diseases
|
August 6, 2025
Comparative Analysis of Initial Full Blood Count Parameters in Adults Infected With <i>Plasmodium falciparum</i> for Classification of Disease Severity and Previous Exposure Across Endemic (Gabon) and Nonendemic (Germany) Settings
Cäcilie von Wedel, Lars Christian Matthies, Clemens Dierks, et al.
Ebiomedicine
|
October 15, 2023
Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial
Dorothea Ekoka Mbassi, Ghyslain Mombo-Ngoma, Jana Held, et al.
BMC Cancer
|
March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
Ermelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon
Ghyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers, et al.
Malaria Journal
|
January 3, 2023
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
Adama Gansane, Moussa Lingani, Adoke Yeka, et al.
Breast (Edinburgh, Scotland)
|
July 26, 2024
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
Caterina Caminiti, Giuseppe Maglietta, Laura Arenare, et al.
Plos Neglected Tropical Diseases
|
May 21, 2024
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting
Gerrit Burger, Rafiou Adamou, Ruth Kreuzmair, et al.
BMJ Open
|
July 1, 2016
Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study
Ghyslain Mombo-Ngoma, Jean Rodolphe Mackanga, Raquel González, et al.
ESMO Open
|
January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A Gravina, P Gargiulo, M De Laurentiis, et al.
Page
of 49